Magnetic Resonance Imaging-Based Volumetric Analysis of Basal Ganglia Nuclei and Substantia Nigra in Patients with Parkinson’s Disease
暂无分享,去创建一个
Chi-Shing Zee | C. Zee | D. Geng | Dao-ying Geng | Yu-Xin Li | Yuxin Li
[1] W. Heiss,et al. Differentiating multiple system atrophy from Parkinson’s disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging , 2002, Journal of neurology, neurosurgery, and psychiatry.
[2] G. Bydder,et al. Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline , 2001, Journal of Neural Transmission.
[3] I. McKeith,et al. MRI Study of Caudate Nucleus Volume in Parkinson’s Disease with and without Dementia with Lewy Bodies and Alzheimer’s Disease , 2003, Dementia and Geriatric Cognitive Disorders.
[4] V Kaasinen,et al. Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperone. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] Y Nakata,et al. Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[6] C Kremser,et al. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD , 2002, Neurology.
[7] Age-related structural changes in the human midbrain: an MR image study , 2001, Neurobiology of Aging.
[8] S H Lisanby,et al. Diminished subcortical nuclei volumes in Parkinson's disease by MR imaging. , 1993, Journal of neural transmission. Supplementum.
[9] J. Degroot,et al. Magnetic resonance imaging of the midbrain in Parkinson's disease , 1986, Annals of neurology.
[10] Yoshiharu Tamakawa,et al. The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. , 2002, AJNR. American journal of neuroradiology.
[11] J. Saint-Cyr,et al. The subthalamic nucleus in the context of movement disorders. , 2004, Brain : a journal of neurology.
[12] J D Speelman,et al. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[13] R. Grossman,et al. MR imaging of Parkinson disease with spin-echo and gradient-echo sequences. , 1988, AJR. American journal of roentgenology.
[14] C Kremser,et al. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy , 2003, Neurology.
[15] A J Lees,et al. Asymmetry of substantia nigra neuronal loss in Parkinson's disease and its relevance to the mechanism of levodopa related motor fluctuations. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[16] Karl J. Friston,et al. Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study. , 1999, Brain : a journal of neurology.
[17] I G McKeith,et al. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. , 1999, Brain : a journal of neurology.
[18] U Klose,et al. Reliability and exactness of MRI‐based volumetry: A phantom study , 1996, Journal of magnetic resonance imaging : JMRI.
[19] T. Hosoya,et al. Evaluation of the substantia nigra in patients with Parkinsonian syndrome accomplished using multishot diffusion-weighted MR imaging. , 1999, AJNR. American journal of neuroradiology.
[20] Michael Hutchinson,et al. MRI correlates of pathology in parkinsonism: segmented inversion recovery ratio imaging (SIRRIM) , 2003, NeuroImage.
[21] Christian Kremser,et al. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease , 2004, NeuroImage.
[22] J. Hedderich,et al. Magnetic Resonance Imaging-Based Morphometry and Landmark Correlation of Basal Ganglia Nuclei , 2002, Acta Neurochirurgica.
[23] M. Skalej,et al. Magnetic resonance imaging–based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy , 1999, Annals of neurology.
[24] H. Gray. Gray's Anatomy , 1858 .
[25] Koichi Okamoto,et al. Structural changes in the midbrain with aging and Parkinson’s disease: an MRI study , 2004, Neurobiology of Aging.
[26] A. Antonini,et al. PET and SPECT functional imaging in Parkinson's disease. , 2004, Sleep medicine.
[27] N. Schuff,et al. Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.
[28] Clement Hamani,et al. Correspondence of microelectrode mapping with magnetic resonance imaging for subthalamic nucleus procedures. , 2005, Surgical neurology.
[29] C. Summerfield,et al. Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia , 2005, Movement disorders : official journal of the Movement Disorder Society.
[30] M Hutchinson,et al. Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging. , 2000, AJNR. American journal of neuroradiology.
[31] Karl J. Friston,et al. Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.
[32] A. Righini,et al. Thin Section MR Study of the Basal Ganglia in the Differential Diagnosis Between Striatonigral Degeneration and Parkinson Disease , 2002, Journal of computer assisted tomography.
[33] M. Yorubulut,et al. T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores. , 2004, Neurology India.